Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Price:
10.53
CNY
6.15%
Market Closed
Market Cap:
4.6B
CNY
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
20.6
Current
22.5
Median
12.8
Industry
Lower
than median
Higher
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=20.6
Enterprise Value
/
5.2B CNY
EBITDA
250.3m CNY
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
11.9
2-Years Forward
EV/EBITDA
11
3-Years Forward
EV/EBITDA
9.5
You don't have any saved screeners yet
